Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 7 | 2018 | 23 | 1.030 |
Why?
|
| Radiotherapy, Intensity-Modulated | 5 | 2020 | 14 | 0.730 |
Why?
|
| Employment | 1 | 2021 | 22 | 0.660 |
Why?
|
| Internship and Residency | 1 | 2021 | 103 | 0.580 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 57 | 0.520 |
Why?
|
| Brachytherapy | 4 | 2021 | 23 | 0.500 |
Why?
|
| Radiation Injuries | 3 | 2011 | 15 | 0.470 |
Why?
|
| Gamma Rays | 1 | 2015 | 8 | 0.440 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 18 | 0.430 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 36 | 0.420 |
Why?
|
| Tomography, Spiral Computed | 2 | 2011 | 10 | 0.400 |
Why?
|
| Cranial Irradiation | 2 | 2010 | 6 | 0.400 |
Why?
|
| Hippocampus | 2 | 2010 | 97 | 0.370 |
Why?
|
| Phantoms, Imaging | 4 | 2020 | 17 | 0.350 |
Why?
|
| Radiotherapy Dosage | 8 | 2021 | 42 | 0.350 |
Why?
|
| Radiometry | 5 | 2017 | 13 | 0.330 |
Why?
|
| Scattering, Radiation | 3 | 2020 | 27 | 0.330 |
Why?
|
| Pluripotent Stem Cells | 1 | 2010 | 2 | 0.320 |
Why?
|
| Radiosurgery | 2 | 2020 | 17 | 0.290 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 247 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2018 | 281 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 195 | 0.250 |
Why?
|
| Humans | 18 | 2021 | 12240 | 0.250 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2018 | 6 | 0.250 |
Why?
|
| Algorithms | 3 | 2018 | 169 | 0.230 |
Why?
|
| Monte Carlo Method | 3 | 2018 | 24 | 0.200 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 16 | 0.200 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2021 | 3 | 0.170 |
Why?
|
| Physics | 1 | 2021 | 3 | 0.170 |
Why?
|
| Sarcoma | 1 | 2021 | 59 | 0.160 |
Why?
|
| Molecular Imaging | 1 | 2020 | 4 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 35 | 0.150 |
Why?
|
| Photons | 1 | 2018 | 4 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2017 | 23 | 0.130 |
Why?
|
| United States | 1 | 2021 | 989 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 252 | 0.120 |
Why?
|
| Radiation Dosage | 1 | 2015 | 23 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2015 | 19 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2006 | 13 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 2 | 2011 | 6 | 0.100 |
Why?
|
| Whole-Body Irradiation | 2 | 2012 | 8 | 0.100 |
Why?
|
| Parotid Gland | 1 | 2014 | 11 | 0.100 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 51 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2011 | 113 | 0.100 |
Why?
|
| Prone Position | 1 | 2011 | 15 | 0.080 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 2 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2011 | 38 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2011 | 90 | 0.080 |
Why?
|
| Relative Biological Effectiveness | 1 | 2010 | 1 | 0.080 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 2 | 0.080 |
Why?
|
| Brain Stem | 1 | 2010 | 7 | 0.080 |
Why?
|
| Dentate Gyrus | 1 | 2010 | 4 | 0.080 |
Why?
|
| Male | 4 | 2015 | 6815 | 0.080 |
Why?
|
| Particle Accelerators | 1 | 2009 | 1 | 0.080 |
Why?
|
| Electrons | 1 | 2009 | 8 | 0.080 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 7 | 0.080 |
Why?
|
| Heart | 1 | 2009 | 42 | 0.080 |
Why?
|
| Larynx | 1 | 2009 | 6 | 0.070 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2009 | 9 | 0.070 |
Why?
|
| Carcinoma | 1 | 2009 | 34 | 0.070 |
Why?
|
| Female | 7 | 2015 | 6974 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 464 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2006 | 8 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 10 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 10 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2006 | 30 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2021 | 1467 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 641 | 0.060 |
Why?
|
| Brain | 1 | 2010 | 707 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2017 | 22 | 0.050 |
Why?
|
| Histocompatibility | 1 | 2004 | 2 | 0.050 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 18 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 69 | 0.040 |
Why?
|
| Middle Aged | 3 | 2014 | 4043 | 0.040 |
Why?
|
| Aged | 3 | 2014 | 4000 | 0.040 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 3 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 21 | 0.030 |
Why?
|
| Water | 1 | 2017 | 21 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 143 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 152 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 3557 | 0.020 |
Why?
|
| Body Burden | 1 | 2012 | 1 | 0.020 |
Why?
|
| Supine Position | 1 | 2011 | 5 | 0.020 |
Why?
|
| X-Ray Film | 1 | 2011 | 2 | 0.020 |
Why?
|
| Artifacts | 1 | 2011 | 12 | 0.020 |
Why?
|
| Software | 1 | 2011 | 26 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 324 | 0.020 |
Why?
|
| Equipment Design | 1 | 2011 | 76 | 0.020 |
Why?
|
| Lung | 1 | 2011 | 76 | 0.020 |
Why?
|
| Metals | 1 | 2011 | 56 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 81 | 0.020 |
Why?
|
| Animals | 2 | 2006 | 2092 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 8 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2009 | 10 | 0.020 |
Why?
|
| Radiation Protection | 1 | 2009 | 1 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2009 | 50 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 258 | 0.020 |
Why?
|
| Rats, Inbred ACI | 1 | 2006 | 1 | 0.020 |
Why?
|
| Chimerism | 1 | 2006 | 1 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 21 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 205 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 407 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Hemibody Irradiation | 1 | 2004 | 1 | 0.010 |
Why?
|
| Papio | 1 | 2004 | 6 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 10 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 10 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 11 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 15 | 0.010 |
Why?
|
| Injections | 1 | 2004 | 22 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2004 | 21 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 44 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 93 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 760 | 0.010 |
Why?
|